About
With 30 years’ experience of executing complex international transactions, Greg is known for leading cross-border, multi-disciplinary teams and delivering innovative, commercially focused solutions.
Greg has a broad corporate finance practice focusing on ECM related transactions (including IPOs (equity and GDRs), introductions, secondary offerings, block trades, private placements), domestic and international public and private M&A. He regularly advises on UKLA Listing Rules and Disclosure and Transparency Rules, the Prospectus Rules, the AIM Rules, the Takeover Code and general corporate law. He also acts for financial advisers on takeovers and frequently speaks at industry conferences on London listings, capital markets trends and corporate governance.
He has advised clients across wide range of sectors, including financial services, real estate, oil and gas, mining and technology. Greg is recognised for his deep expertise in Africa and emerging markets, and has extensive experience of advising on China related transactions - acting for Chinese clients transacting on outbound China transactions, clients who are counter parties to Chinese parties and clients transacting in China.
Experience
Representative capital markets transactions include:
- advising Citigroup and Mizuho, acting as joint book-running managers and underwriters in connection with Diversified Energy Company PLC’s underwritten public offering of 8,500,000 ordinary shares for total gross proceeds of approximately $123.3 million;
- advising Saudi Fransi Capital (as underwriter, bookrunner, financial advisor and lead manager) and EFG Hermes KSA (as underwriter and bookrunner), on the initial public offering of Almoosa Health Company, a leading healthcare provider in Saudi Arabia, on the Main Market of the Saudi Exchange (the total offering value amounted to SAR 1.69 billion (US$449 million);
- advising Geely Automotive on the acquisition of its stake in Aston Martin Lagonda plc and on subsequent ABBs to maintain its percentage stake in Aston Martin Lagonda plc;
- advising Woodside Energy Group Limited on its c.US$45bn listing on the London Stock Exchange; and
- advising Weichai Power Co., Ltd on its strategic equity investment and framework agreement with AIM-listed Ceres Power plc, developer of fuel cell technology.
Representative M&A transactions include:
- advising NewRiver REIT plc (NewRiver), on its recommended offer for Capital & Regional PLC in a stock-and-cash deal valued at approximately $196.1 million;
- advising Woodside Energy Group Limited on the UK aspects of its acquisition of BHP’s portfolio of oil and gas assets;
- advising Square, Inc. on the UK aspects of its acquisition of Afterpay Limited;
- advising the Eliison Foundation on the structuring and establishment of clinical research facilities in 7 African jurisdictions;
- advising a Dutch investment company in (i) the auction sale of its interest in the Ghanaian Tema LNG project to African Infrastructure Investment Managers; and (ii) the sale of its interest in the Ghanaian Tema LNG project to Helios;
- advising NextView Capital in its acquisition of a 19.9% equity interest in Bacanora Minerals Ltd (listed on AIM and TSX);
- advising BHP on the acquisition of its stake in Solgold plc; and
- advising Luye Pharma, the Hong Kong listed group on its US$546 million acquisition of pharmaceutical rights / assets in 51 countries from AstraZeneca.
